Table I.
Association between miR-1307-3p expression and the clinicopathological characteristics of patients with gastric cancer.
| miR-1307-3p expression level | ||||
|---|---|---|---|---|
| Factors | Total (n=117) | Low (n=52) | High (n=65) | P-value |
| Age, years | 0.479 | |||
| ≤60 | 57 | 25 | 32 | |
| >60 | 60 | 27 | 33 | |
| Sex | 0.429 | |||
| Male | 68 | 26 | 42 | |
| Female | 49 | 26 | 23 | |
| Tumor size, cm | 0.244 | |||
| ≤3 | 52 | 22 | 30 | |
| >3 | 65 | 30 | 35 | |
| Differentiation | 0.279 | |||
| Well + moderate | 73 | 41 | 32 | |
| Poor | 44 | 11 | 33 | |
| Lymph node metastasis | 0.145 | |||
| Negative | 63 | 37 | 26 | |
| Positive | 54 | 15 | 39 | |
| TNM stage | 0.027 | |||
| I–II | 79 | 43 | 36 | |
| III–IV | 38 | 9 | 29 | |
miR, microRNA; TNM, Tumor-Node-Metastasis.